SEC Form 4 · accession 0001651844-16-000012
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Jan 11, 2016
Accepted (ET)
Jan 13, 2016 · 10:58 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 11, 2016 | P | 10,000 | $2.40 | A | 2,647,550 | D | |
| Common Stock | Jan 12, 2016 | P | 10,000 | $2.48 | A | 2,657,550 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.